Found 0 matching trials
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
N/APoly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Cannabis Extract in Refractory Epilepsy Study
PHASE3The purpose of this study is to examine whether a low dose of CBD+THC will ...
Location
University Hospital Campus, London Health Sciences Centre
BI 443651 Methacholine Challenge
PHASE1The primary objective of this study is to investigate safety and tolerabili...
Location
The Medicines Evaluation Unit
Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
PHASE2The goal of this clinical trial is to compare full dose MDMA-assisted thera...
Location
Offices of Dr. Ingrid Pacey MBBS FRCP[C]
Combinatorial Therapy to Induce an HIV Remission
PHASE1Combination approaches will almost certainly be required to generate durabl...
Location
Zuckerberg San Francisco General Hospital, University of California San Francisco
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
PHASE2This study is a multicenter, prospective, randomized phase II trial aimed a...
Location
Zhejiang Cancer Hospital
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
PHASE1This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
A Study of Belzutifan (MK-6482) in Participants With Hepatic Impairment (MK-6482-020)
PHASE1The primary purpose of this study is to compare the plasma pharmacokinetics...
Location
Orlando Clinical Research Center ( Site 0001)
Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants.
PHASE1The primary objective of this study is to characterise the pharmacokinetics...
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center